New Breast Cancer Study Findings Have Been Reported from Shenyang Pharmaceutical University (Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer)

MLA

“New Breast Cancer Study Findings Have Been Reported from Shenyang Pharmaceutical University (Characterization of HJ-PI01 as a Novel Pim-2 Inhibitor That Induces Apoptosis and Autophagic Cell Death in Triple-Negative Human Breast Cancer).” Women’s Health Weekly, Oct. 2016, p. 2678. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.466728915&authtype=sso&custid=ns315887.

APA

New Breast Cancer Study Findings Have Been Reported from Shenyang Pharmaceutical University (Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer). (2016, October 20). Women’s Health Weekly, 2678.

Chicago

Women’s Health Weekly. 2016. “New Breast Cancer Study Findings Have Been Reported from Shenyang Pharmaceutical University (Characterization of HJ-PI01 as a Novel Pim-2 Inhibitor That Induces Apoptosis and Autophagic Cell Death in Triple-Negative Human Breast Cancer),” October 20. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.466728915&authtype=sso&custid=ns315887.